Pyrosequencing, a high-throughput method for detecting single nucleotide polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum

Journal of Clinical Microbiology

Volumn 44, Issue 11, 2006, Pages 3900-3910

  Zhou, Zhiyong ^a,b   Poe, Amanda C ^a,b   Limor, Josef ^c   Grady, Katharine K ^a   Goldman, Ira ^a   McCollum, Andrea M ^a,b,d   Escalante, Ananias A ^e   Barnwell, John W ^a   Udhayakumar, Venkatachalam ^a  

^a Centers for Disease Control and Prevention   (United States)

^b ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

^c NATIONAL CENTER FOR PREPAREDNESS DETECTION AND CONTROL OF INFECTIOUS DISEASES   (United States)

^d EMORY UNIVERSITY   (United States)

^e ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; PROTOZOAL DNA;

ARTICLE; DNA SEQUENCE; HIGH THROUGHPUT SCREENING; MALARIA; MALARIA FALCIPARUM; NONHUMAN; PARASITE IDENTIFICATION; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STRAIN DIFFERENCE;

ANIMALS; COSTS AND COST ANALYSIS; DIHYDROPTEROATE SYNTHASE; PLASMODIUM FALCIPARUM; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TETRAHYDROFOLATE DEHYDROGENASE;

PLASMODIUM FALCIPARUM;

EID: 33750931085     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01209-06     Document Type: Article

References (30)

1. Abdel-Muhsin, A. M., L. C. Ranford-Cartwright, A. R. Medani, S. Ahmed, S. Suleiman, B. Khan, P. Hunt, D. Walliker, and H. A. Babiker. 2002. Detection of mutations in the Plasmodium falciparum dihydrofolate reductase (dhfr) gene by dot-blot hybridization. Am. J. Trop. Med. Hyg. 67:24-27.
2. Ahmadian, A., M. Ehn, and S. Hober. 2006. Pyrosequencing: history, biochemistry and future. Clin. Chim. Acta 363:83-94.
3. Ahmed, A., D. Bararia, S. Vinayak, M. Yameen, S. Biswas, V. Dev, A. Kumar, M. A. Ansari, and Y. D. Sharma. 2004. Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance. Antimicrob. Agents Chemother. 48:879-889.
4. Alifrangis, M., S. Enosse, R. Pearce, C. Drakeley, C. Roper, I. F. Khalil, W. M. Nkya, A. M. Ronn, T. G. Theander, and I. C. Bygbjerg. 2005. A simple, high-throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in the dihydrofolate reductase, dihydropteroate synthase, and P. falciparum chloroquine resistance transporter genes using polymerase chain reaction and enzyme-linked immunosorbent assay-based technology. Am. J. Trop. Med. Hyg. 72:155-162.
5. Anderson, T. J., and C. Roper. 2005. The origins and spread of antimalarial drug resistance: lessons for policy makers. Acta Trop. 94:269-280.
6. Basco, L. K., R. Tahar, A. Keundjian, and P. Ringwald. 2000. Sequence variations in the genes encoding dihydropteroate synthase and dihydrofolate reductase and clinical response to sulfadoxine-pyrimethamine in patients with acute uncomplicated falciparum malaria. J. Infect. Dis. 182:624-628.
7. Brooks, D. R., P. Wang, M. Read, W. M. Watkins, P. F. Sims, and J. E. Hyde. 1994. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase:dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur. J. Biochem. 224:397-405.
8. Clarke, S. C. 2005. Pyrosequencing: nucleotide sequencing technology with bacterial genotyping applications. Exp. Rev. Mol. Diagn. 5:947-953.
9. Contreras, C. E., J. F. Cortese, A. Caraballo, and C. V. Plowe. 2002. Genetics of drug-resistant Plasmodium falciparum malaria in the Venezuelan state of Bolivar. Am. J. Trop. Med. Hyg. 67:400-405.
10. Cowman, A. F., M. J. Morry, B. A. Biggs, G. A. Cross, and S. J. Foote. 1988. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 85:9109-9113.
11. Curtis, J., M. T. Duraisingh, J. K. Trigg, H. Mbwana, D. C. Warhurst, and C. F. Curtis. 1996. Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in Tanzania. Trans. R. Soc. Trop. Med. Hyg. 90:678-680.
12. Duraisingh, M. T., J. Curtis, and D. C. Warhurst. 1998. Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Exp. Parasitol. 89:1-8.
13. Durand, R. E. J., J. Sayeh, J.-F. Delabre, A. Marmorat-Khuong, J. P. Di Piazza, and J. Le Bras. 2000. Use of molecular beacons to detect an antifolate resistance-associated mutation in Plasmodium falciparum. Antimicrob. Agents Chemother. 44:3461-3464.
14. Eberl, K. J., T. Jelinek, A. O. Aida, G. Peyerl-Hoffmann, C. Heuschkel, A. O. el Valy, and E. M. Christophel. 2001. Prevalence of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from southern Mauritania. Trop. Med. Int. Health 6:756-760.
15. Gregson, A., and C. V. Plowe. 2005. Mechanisms of resistance of malaria parasites to antifolates. Pharmacol. Rev. 57:117-145.
16. Hunt, P., R. Fawcett, R. Carter, and D. Walliker. 2005. Estimating SNP proportions in populations of malaria parasites by sequencing: validation and applications. Mol. Biochem. Parasitol. 143:173-182.
17. Kublin, J. G., F. K. Dzinjalamala, D. D. Kamwendo, E. M. Malkin, J. F. Cortese, L. M. Martino, R. A. Mukadam, S. J. Rogerson, A. G. Lescano, M. E. Molyneux, P. A. Winstanley, P. Chimpeni, T. E. Taylor, and C. V. Plowe. 2002. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J. Infect. Dis. 185:380-388.
18. Nair, S., A. Brockman, L. Paiphun, F. Nosten, and T. J. Anderson. 2002. Rapid genotyping of loci involved in antifolate drug resistance in Plasmodium falciparum by primer extension. Int. J. Parasitol. 32:852-858.
19. Nordfors, L., J. Marten, G. Sandberg, C. Lavebratt, S. Sengul, M. Schalling, and P. Arner. 2002. Large-scale genotyping of single nucleotide polymorphisms by Pyrosequencing™ and validation against the 5′ nuclease (Taqman®) assay. Hum. Mutat. 19:395-401.
20. Pati, N., V. Schowinsky, O. Kokanovic, V. Magnuson, and S. Ghosh. 2005. A comparison between SNaPshot, pyrosequencing, and biplex invader SNP genotyping methods: accuracy, cost, and throughput. J. Biochem. Biophys. Methods 60:1-12.
21. Peterson, D. S., D. Walliker, and T. E. Wellems. 1988. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc. Natl. Acad. Sci. USA 85:9114-9118.
22. Plowe, C. V. 2003. Monitoring antimalarial drug resistance: making the most of the tools at hand. J. Exp. Biol. 206:3745-3752.
23. Plowe, C. V., A. Djimde, M. Bouare, O. Doumbo, and T. E. Wellems. 1995. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am. J. Trop. Med. Hyg. 52:565-568.
24. Plowe, C. V., J. F. Cortese, A. Djimde, O. C. Nwanyanwu, W. M. Watkins, P. A. Winstanley, J. G. Estrada-Franco, R. E. Mollinedo, J. C. Avila, J. L. Cespedes, D. Carter, and O. K. Doumbo. 1997. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J. Infect. Dis. 176:1590-1596.
25. Reeder, J. C., K. H. Rieckmann, B. Genton, K. Lorry, B. Wines, and A. F. Cowman. 1996. Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea. Am. J. Trop. Med. Hyg. 55:209-213.
26. Shaio, M.-F., P. Wang, C.-S. Lee, P. F. D. Sims, and J. E. Hyde. 1998. Development and comparison of quantitative assays for the dihydropteroate synthetase codon 540 mutation associated with sulfadoxine resistance in Plasmodium falciparum. Parasitology 116:203-210.
27. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
28. Wang, P., M. Read, P. F. Sims, and J. E. Hyde. 1997. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Mol. Microbiol. 23:979-986.
29. Wilson, P. E., A. P. Alker, and S. R. Meshnick. 2005. Real-time PCR methods for monitoring antimalarial drug resistance. Trends Parasitol. 21:278-283.
30. Zolg, J. W., G. X. Chen, and J. R. Plitt. 1990. Detection of pyrimethamine resistance in Plasmodium falciparum by mutation-specific polymerase chain reaction. Mol. Biochem. Parasitol. 39:257-265.